USClinicalTrials.gov【Trial record】
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/2RecruitingSource updated: Oct 1, 2026
Cancer types
Colorectal Cancer
Colon and rectal cancer. 94 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 94 of 94
Highlight terms:
Build a discussion list0 selected
Select the public official records you want to take to your appointment, then generate a list. Nothing is ranked or recommended — the list only reproduces titles and links.
Not signed in — up to 5 records per list. Sign in for higher free limits, or see Pro for more exports.
USEUCNOTHERClinicalTrials.gov【Trial record】
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Phase 3RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
Phase 2Not yet recruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
Butyrophilins Role in Colon Cancer
Not applicableRecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
Not applicableActive, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Not applicableRecruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2RecruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】
Mailed FIT-Based Outreach Interventions
Not applicableNot yet recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Enrolling by invitationSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Phase 2RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
Phase 2RecruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Not applicableRecruitingSource updated: Oct 1, 2026
EUCNOTHERClinicalTrials.gov【Trial record】
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
Phase 1/2RecruitingSource updated: Oct 1, 2026
CNClinicalTrials.gov【Trial record】
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Early Phase 1RecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1Active, not recruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
Phase 3Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
TLR9 Immunotherapy for Peritoneal Carcinomatosis
Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
Not applicableActive, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1RecruitingSource updated: Sep 30, 2026
USOTHERClinicalTrials.gov【Trial record】
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
Phase 1Active, not recruitingSource updated: Sep 30, 2026
CNClinicalTrials.gov【Trial record】
A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma)
RecruitingSource updated: Sep 30, 2026
USEUClinicalTrials.gov【Trial record】
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
Phase 1/2Active, not recruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Phase 1/2RecruitingSource updated: Sep 30, 2026
EUClinicalTrials.gov【Trial record】
Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Phase 2RecruitingSource updated: Sep 30, 2026
EUClinicalTrials.gov【Trial record】
Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)
Phase 2Active, not recruitingSource updated: Sep 30, 2026
EUClinicalTrials.gov【Trial record】
Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer
Not applicableRecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
PRE-ISPY Phase I/II Oncology Platform Program
Phase 1/2RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Phase 2Not yet recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
Not applicableRecruitingSource updated: Sep 30, 2026
EUClinicalTrials.gov【Trial record】
Optimizing Participation In Colorectal Cancer Screening By Direct Invitation Of Non Responders By General Practitionners
Not applicableNot yet recruitingSource updated: Sep 29, 2026
EUClinicalTrials.gov【Trial record】
A One-year Follow-up of Incisional Hernia Formation Between Device Assisted and Manual Laparotomy Closure
Not applicableRecruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland
Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Phase 3RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study Testing SOT109 for the First Time in Patients, to Assess How Safe SOT109 is, How Well it Works, and How the Body Handles it in Patients With Advanced Colorectal Cancer That Can Not be Removed by Surgery or is Metastatic
Phase 1/2Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Phase 2RecruitingSource updated: Aug 14, 2026
CNClinicalTrials.gov【Trial record】
Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer
Not applicableRecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
Phase 2RecruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis
Phase 2RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Phase 1Not yet recruitingSource updated: Aug 14, 2026
CNClinicalTrials.gov【Trial record】
NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC
Phase 2Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
Not applicableRecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
Phase 1Active, not recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Not applicableRecruitingSource updated: Aug 14, 2026
EUClinicalTrials.gov【Trial record】
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group
Phase 2Active, not recruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
Reducing Neoplasia Recurrence After Non-thermal Endoscopic Resection of Large Colorectal Polyps
Not applicableNot yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Phase 3RecruitingSource updated: Aug 14, 2026
CNClinicalTrials.gov【Trial record】
Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients
Not applicableRecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Phase 1/2Active, not recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Phase 1/2RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Not applicableRecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Genomic Services Research Program
RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Phase 2RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Men at High Genetic Risk for Prostate Cancer
RecruitingSource updated: Aug 13, 2026
EUClinicalTrials.gov【Trial record】
Microbiome Testing for the Screening of Colorectal Cancer
RecruitingSource updated: Aug 13, 2026
EUClinicalTrials.gov【Trial record】
Microbiome-based Diagnostic Tool for the Screening of Colorectal Cancer (GUILTI)
RecruitingSource updated: Aug 13, 2026
CNClinicalTrials.gov【Trial record】
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
Phase 1/2RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
Phase 1/2RecruitingSource updated: Aug 13, 2026
OTHERClinicalTrials.gov【Trial record】
Quality of Life of Patients After Rectal Cancer Resection .
Not yet recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Phase 2RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Phase 2Active, not recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
Phase 1/2RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
Phase 2Active, not recruitingSource updated: Aug 13, 2026
CNCDE【Guideline / public regulatory information】
CDE 临床试验默示许可 — clinical trial implied licence notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 优先审评公示 — priority review listings
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 受理品种信息 — applications accepted for review
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 指导原则 — published technical guidance documents
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 突破性治疗公示 — breakthrough therapy designation notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 附条件批准品种 — conditionally approved products list
Index verified: Aug 16, 2026
CNChiCTR【Guideline / public regulatory information】
ChiCTR — Chinese Clinical Trial Registry, public search
Index verified: Aug 16, 2026
EUCTIS【Guideline / public regulatory information】
CTIS public register — search clinical trials authorised in the EU/EEA
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — CHMP meeting highlights and opinions on new medicines
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — searchable database of authorised medicines in the EU
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — gastrointestinal cancers
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — public index by tumour type
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — supportive and palliative care section
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — expanded access (compassionate use) information for patients
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — oncology (cancer) / hematologic malignancies approval notifications
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — ongoing accelerated approvals for oncology indications
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — palliative care category listing
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — public index by cancer type (free registration)
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines for Patients — plain-language versions
Index verified: Aug 16, 2026
CNNMPA【Guideline / public regulatory information】
NMPA 药品 — national drug approval announcements
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Index verified: Aug 16, 2026